Our Mission
Clinical Trial Finder
- Common Clinical Trial Acronyms and Abbreviations
- Understanding the Phases of Clinical Trials
Blog
About
- Our team
- Info
- David Wallace Bio
  David Wallace
  
  Founder & CEO of MPN Cancer Connection and PV Reporter | Patient Advocate
  When David was diagnosed with PV in 2009, at the age of 47, he soon learned there was limited and often conflicting information available on Myeloproliferative Neoplasms (MPNs). He also realized early on in his diagnosis, the importance of advocating for himself to best manage his polycythemia vera (PV). David was grateful for the early support and guidance of fellow MPN patients on his journey and wanted a way to give back to the MPN community. With a professional background in business administration and sociology, David has a passion for finding solutions and helping others. In 2013, David used his skill set to create PV Reporter, a comprehensive patient-focused website for MPNs. David refers to his site as a hub for patients to begin to research their cancer. Whether a patient, caregiver or healthcare provider, PV Reporter offers visitors a wealth of educational resources, patient stories, articles, and the latest news on the treatment for MPNs, helping MPN patients and their caregivers stay informed, connected and empowered. In 2015, along with the help of others, David founded a non-profit MPN Cancer Connection (MPN-CC), a patient-led 501©3 formed to create awareness that MPN patients are “cancer patients” and should have complete access to local and national programs and benefits. David’s philosophy is to educate patients to become their own advocates so that they can make informed decisions on their treatment. David’s dedication to the MPN community is further evidenced through his work and awards:
  - Selected to endorse 2018 NCCN guidelines for MPN patients by MPN Cancer Connection
  - Selected to represent the United States as a patient advocate by MPNs Advocate Network International Conference 2016-2019
  - Recipient of MPN Hero Award 2016
  - Published in MD Anderson Cancer Center MPN Focus Newsletter Fall 2016
  - Appearance on “The Doctors” TV show in 2015 to promote MPN awareness
  - Awarded Press Credentials for American Society of Hematology Conference 2014-2019
  - Contributor to Patient Power MPN educational videos
  David lives in Charlotte, North Carolina. When he’s not working, David enjoys spending time with family, listening to live music, attending outdoor festivals, watching the Carolina Panthers, riding his motorcycle, traveling and of course having his beloved Aussiedoodle Bailey by his side.
Resources
Our Vision
- Donate
Contact

Donate

Blog

December 30, 2021

Published by pvreporter at December 30, 2021

Categories

New FDA Approved Treatment for Polycythemia Vera

by David Wallace Patients are Asking – MPN Expert Dr. Abu-Zeinah discusses Ropeginterferon, FDA Approved Treatment for Polycythemia Vera Episode 3 of 3 Ropeginterferon / BESREMi […]

December 21, 2021

Published by pvreporter at December 21, 2021

Categories

The Health Benefits of Social Connections for Myeloproliferative Neoplasm Patients

by Lou Ann Donovan We all enjoy getting together with friends and attending family gatherings from time to time. Such occasions give us an opportunity to […]

November 30, 2021

Published by pvreporter at November 30, 2021

Categories

Reducing MPN Related Stress with Mindfulness and Healthy Lifestyle

by Lou Ann Donovan Stress and the Body Stress is a natural physical and mental response to life experiences. Some stress is even good and can […]

October 9, 2021

Published by pvreporter at October 9, 2021

Categories

MPN Clinical Trials & Drugs 2021 News

Patients are Asking – MPN Expert Dr. Andrew Kuykendall Episode 2 of 3 Update on MPN Clinical Trials and new drugs in development for 2021 […]

June 24, 2021

Published by pvreporter at June 24, 2021

Categories

Patients are Asking

Episode 1 of 3 in Patients are Asking Series What symptoms should I look for to see if I might be progressing from polycythemia vera to […]

May 18, 2021

thumbnail of Bone Marrow Soluble Mediator Signatures of Patients with MPNs

Published by pvreporter at May 18, 2021

Categories

Bone Marrow Soluble Mediator Signatures of Patients with MPNs

Abstract: Background: Essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF) are clonal hematological diseases classified as Philadelphia chromosome-negative myeloproliferative neoplasms (MPN). MPN pathogenesis is […]